S. Shambhavi, “Efficacy of Infliximab Versus Vedolizumab in the Management of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review and Meta-Analysis”, World J Oncol, vol. 16, no. 4, pp. 331–341, Jul. 2025, doi: 10.14740/wjon2613.